PATENT CLAIM ANALYSIS

Application Number: 16229784
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-08
Patent Classification: ["514", "170000"]

Abstract:
The present invention relates to a long-term therapy including repeated treatment courses of ulipristal acetate or any metabolite thereof for treating uterine fibroids. The present invention also relates to a combined therapy applying ulipristal acetate with a progestin in order to improve the currently used treatment for uterine fibroids.

Claim (Index 11):
A method of treating uterine fibroids in a patient in need thereof, comprising administering to the patient ulipristal acetate or a metabolite thereof in a therapeutically effective amount in sequential treatment periods, wherein each treatment period lasts 2-6 months and each treatment period is followed by a drug-free period.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 98.0
- Lexical Diversity: 1.45714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14781759', '14386726', '13976895', '15942802', '14131857']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.73872102843763
- 35 USC 102 Novelty (BERT): 0.5660944154816635
- Combined Prediction Score: 0.7214583671420334
- Mean Citation Score: 273.19006
- Max Citation Score: 487.2629
- Similarity Product: 339.2374618545711

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test